AB 19606
|
Antibiotic Susceptible type Strain.
|
National Collection of type cultures
|
AB 14
|
MDR PFGE defined UK OXA-23 clone 1 OXA-23-like carbapenemase producer.
|
Dr J Turton, Public Health England, Colindale, UK
|
AB 16
|
MDR PFGE defined UK OXA-23 clone 2 OXA-23 carbapenemase producer.
|
Dr J Turton, Public Health England, Colindale, UK
|
AB 186
|
MDR PFEG defined UK ‘burn’ strain, OXA-23 producer.
|
Dr J Turton, Public Health England, Colindale, UK
|
AB 202
|
Tigecycline-resistant strain UK OXA-23 clone 1 isolate.
|
Barts Health NHS Trust, London, UK
|
AB 205
|
Colistin resistant UK OXA-23 clone 1 isolate.
|
Barts Health NHS Trust, London, UK
|
AB 292
|
MDR PFGE-defined OXA-23-like carbapenemase producer.
|
Barts Health NHS Trust, London, UK
|
AB 306
|
MDR NDM-1 carbapenemase producer.
|
Barts Health NHS Trust, London, UK
|
AB 308 |
MDR NDM-2 carbapenemase producer. |
S. Gottig, Goethe Universistat, Frankfurt, Germany |